SCHEMBL17561896

SCHEMBL17561896

O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccc(N2CCOC2=O)c(-c2cccnc2)c1

nearest known ligand 0.84

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.84
▸ OPRM1 P35372 1/20 0.58
▸ KCNH2 Q12809 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16860372 0.92 ABL1 (1.00) ABL1KCNH2
SCHEMBL19904236 0.85 ABL1 (0.82) ABL1OPRM1KCNH2
SCHEMBL16860382 0.81 ABL1 (1.00) ABL1
SCHEMBL15391590 0.80 ABL1 (1.00) ABL1KCNH2
SCHEMBL16860333 0.80 ABL1 (1.00) ABL1KCNH2
SCHEMBL16864699 0.80 ABL1 (0.79) ABL1KCNH2
SCHEMBL16714099 0.79 ABL1 (1.00) ABL1OPRM1KCNH2
SCHEMBL16714132 0.78 ABL1 (1.00) ABL1OPRM1KCNH2
SCHEMBL15391237 0.78 ABL1 (1.00) ABL1OPRM1KCNH2
SCHEMBL17561771 0.78 ABL1 (0.89) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278981-B2 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVARTIS AG (CH) 2016-03-08 — — US disclosed
Send feedback